December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
How ADCs are redefining cancer treatment – Zymeworks Inc.
Aug 23, 2024, 16:19

How ADCs are redefining cancer treatment – Zymeworks Inc.

Zymeworks Inc. shared a post on LinkedIn:

“Ongoing innovations in antibody-drug conjugates (ADCs) are revolutionizing cancer treatment.

Breakthroughs in linker-payload technologies and personalized medicine are enhancing therapeutic benefit and enabling treatments tailored to individual patients, providing new hope across various malignancies.

Explore how advancements in ADCs are redefining cancer treatment and our unique approach to their design and development in this article from Drug Target Review.

Image preview

Authors: Paul Moore, Raffaele Colombo and Jamie Rich
How ADCs are redefining cancer treatment - Zymeworks Inc.

Source: Zymeworks Inc./LinkedIn